Antonella M. Ampollini
Milan, 20122, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Correction: Navone et al. Role of Luteolin as Potential New Therapeutic Option for Patients with Glioblastoma Through Regulation of Sphingolipid Rheostat. Int. J. Mol. Sci. 2024, 25, 130.
Journal: International journal of molecular sciences
Published: April 30, 2026
Perilead Edema in Deep Brain Stimulation: Long-Term Outcomes and Etiologic Correlates.
Journal: Neuromodulation : journal of the International Neuromodulation Society
Published: June 26, 2025
Triple perspective: assessing deep brain stimulation outcomes in Parkinson's disease.
Journal: BMC neurology
Published: April 30, 2025
Cognitive effects of adaptive deep brain stimulation in Parkinson's disease: stability without risk.
Cognitive effects of adaptive deep brain stimulation in Parkinson's disease: stability without risk.
Journal: European journal of medical research
Published: April 18, 2025
Exploring the relationship between dystonia and STN-DBS in Parkinson's disease: insights from a single-centre cohort.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: December 30, 2024
Can total electrical energy (TEED) after subthalamic DBS alter verbal fluency in Parkinson's disease patients? A preliminary evidence.
Journal: CNS spectrums
Published: October 28, 2024
The Protective Role of Cognitive Reserve: A Preliminary Study on Parkinsonian Patients Undergoing Deep Brain Stimulation.
Journal: Journal of clinical medicine
Published: July 04, 2024
Deep Brain Stimulation in Parkinson Disease: A Switch for On/Off Dystonia.
Journal: World neurosurgery
Published: June 28, 2024
Case report: Improvement of gait with adaptive deep brain stimulation in a patient with Parkinson's disease.
Journal: Frontiers in bioengineering and biotechnology
Published: May 05, 2024
Testing calpain inhibition in tumor endothelial cells: novel targetable biomarkers against glioblastoma malignancy.
Journal: Frontiers in oncology
Published: December 13, 2023
Role of Luteolin as Potential New Therapeutic Option for Patients with Glioblastoma through Regulation of Sphingolipid Rheostat.
Journal: International journal of molecular sciences
Published: October 25, 2023
Last Updated: 09/26/2026